The eldest of older adults living with HIV: response and adherence to highly active antiretroviral therapy

The American Journal of Medicine
Fátima BrañasJosé Antonio Serra

Abstract

The study objective was to analyze the characteristics and the response to therapy in the eldest of the older adults living with human immunodeficiency virus. The study included a cohort of patients with human immunodeficiency virus aged 55 years or more on initiating highly active antiretroviral therapy (HAART). Immunologic and virologic response, morbidity, and mortality were assessed. Patients were categorized as aged less than 65 years and 65 years or more. A total of 112 patients were included (82 patients aged<65 years and 30 patients aged> or =65 years). There were no differences between the age groups in baseline characteristics, survival, and virologic response. There was a trend toward better adherence and a lower CD4+ cell increase after HAART in the older group. A relationship was found between lower CD4+ cell increase after HAART and advanced age. We found the best adherence to treatment in the eldest of the older adults, and this has been shown to be the only protective independent factor related to virologic failure.

References

Sep 21, 1995·The New England Journal of Medicine·R E ChaissonR D Moore
Oct 17, 2002·Drugs & Aging·Roberto Manfredi
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John L Perez, Richard D Moore
Apr 3, 2007·The American Journal of Medicine·Michael J MugaveroCharles Hicks

❮ Previous
Next ❯

Citations

Mar 10, 2010·Archives of Internal Medicine·Rebecca LodwickAndrew N Phillips
May 23, 2012·AIDS Research and Human Retroviruses·José R BlancoUNKNOWN CoRIS
Jun 4, 2011·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Allison L AgwuUNKNOWN HIV Research Network
Apr 19, 2013·Future Virology·Vanessa PirroneBrian Wigdahl
Jun 6, 2014·AIDS Patient Care and STDs·Shuntai ZhouDavid A Wohl
Apr 7, 2011·AIDS and Behavior·Carmen OrtegoJavier Vejo
Mar 22, 2013·Expert Opinion on Drug Metabolism & Toxicology·John C SchoenPeter L Anderson
Oct 29, 2013·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de expertos de GeSIDA y Plan Nacional sobre el Sida
May 7, 2011·Gaceta sanitaria·Carmen OrtegoFrancisco Javier Llorca
Jan 11, 2011·The Journal of the Association of Nurses in AIDS Care : JANAC·Kathleen M Nokes
Jun 18, 2010·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de Expertos de Gesida, UNKNOWN Plan Nacional sobre el Sida
Feb 28, 2009·Enfermedades infecciosas y microbiología clínica·UNKNOWN Panel de expertos de Gesida y Plan Nacional sobre el Sida
May 16, 2009·Revista española de geriatría y gerontología·Fátima Brañas, José Antonio Serra
Aug 7, 2013·The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases·Karina Mota RibeiroUnaí Tupinambás
Jun 10, 2010·Journal of the International Association of Physicians in AIDS Care : JIAPAC·Marco RuizJustina Ogbuokiri
Feb 13, 2018·BioMed Research International·Eugenia NegredoBonaventura Clotet
Jun 24, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Luis ManriqueOluwatoyin M Adeyemi
Dec 10, 2016·The Journal of the Association of Nurses in AIDS Care : JANAC·Tiffany ChennevilleCarina Rodriguez
Feb 6, 2021·International Journal of Clinical Pharmacy·José Manuel Vinuesa-HernandoRaquel Gracia-Piquer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.